[1] Thomas ME, Blaine C, Dawnay A, et al.The definition of acute kidney injury and its use in practice[J]. Kidney Int, 2015,87(1):62-73.
[2] Mehta RL, Cerdá J, Burdmann EA, et al.International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology[J]. Lancet,2015,385(9987):2616-2643.
[3] Tao Li PK, Burdmann EA, Mehta RL.Acute kidney injury: global health alert[J]. Int J Organ Transplant Med,2013,4(1):1-8.
[4] Siew ED, Davenport A.The growth of acute kidney injury: a rising tide or just closer attention to detail?[J]. Kidney Int,2015,87(1):46-61.
[5] Ishani A, Xue JL, Himmelfarb J, et al.Acute kidney injury increases risk of ESRD among elderly[J]. J Am Soc Nephrol,2009,20(1):223-228.
[6] Wald R, Quinn RR, Luo J, et al.Chronic dialysis and death among survivors of acute kidney injury requiring dialysis[J]. JAMA,2009,302(11):1179-1185.
[7] Lafrance JP, Miller DR.Acute kidney injury associates with increased long-term mortality[J]. J Am Soc Nephrol,2010,21(2):345-352.
[8] Coca SG, Singanamala S, Parikh CR.Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis[J]. Kidney Int,2012,81(5):442-448.
[9] Coca SG, Yusuf B, Shlipak MG, et al.Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis[J]. Am J Kidney Dis,2009,53(6):961-973.
[10] Che X, Xie Y, Wang C, et al.Blood HCO3- concentration predicts the long-term prognosis of acute kidney injury patients[J]. Biomark Med,2014,8(10):1219-1226.
[11] Basile DP, Donohoe D, Roethe K, et al.Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function[J]. Am J Physiol Renal Physiol,2001,281(5):F887-F899.
[12] Kang DH, Kanellis J, Hugo C, et al.Role of the microvascular endothelium in progressive renal disease[J]. J Am Soc Nephrol,2002,13(3):806-816.
[13] Nangaku M.Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure[J]. Nephron Exp Nephrol,2004,98(1):e8-e12.
[14] Berger K, Moeller MJ.Mechanisms of epithelial repair and regeneration after acute kidney injury[J]. Semin Nephrol,2014,34(4):394-403.
[15] Xu Y, Xie Y, Shao X, et al.L-FABP: A novel biomarker of kidney disease[J]. Clin Chim Acta,2015,445:85-90.
[16] Koyner JL, Garg AX, Coca SG, et al.Biomarkers predict progression of acute kidney injury after cardiac surgery[J]. J Am Soc Nephrol,2012,23(5):905-914.
[17] McMahon GM, Waikar SS. Biomarkers in nephrology: Core curriculum 2013[J]. Am J Kidney Dis,2013,62(1):165-178.
[18] Waikar SS, Betensky RA, Bonventre JV.Creatinine as the gold standard for kidney injury biomarker studies?[J]. Nephrol Dial Transplant,2009,24(11):3263-3265.
[19] Adiyanti SS, Loho T. Acute Kidney Injury (AKI) biomarker[J]. Acta Med Indones,2012,44(3):246-255.
[20] Bonventre JV.Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more[J]. Nephrol Dial Transplant,2009,24(11):3265-3268.
[21] Siew ED, Ware LB, Ikizler TA.Biological markers of acute kidney injury[J]. J Am Soc Nephrol,2011,22(5):810-820.
[22] Nejat M, Pickering JW, Devarajan P, et al.Some biomarkers of acute kidney injury are increased in pre-renal acute injury[J]. Kidney Int,2012,81(12):1254-1262.
[23] Xie Y, Wang Q, Wang C, et al.Association between the levels of urine kidney injury molecule-1 and the progression of acute kidney injury in the elderly[J]. PLoS One,2017,12(2):e0171076.
[24] Xue W, Xie Y, Wang Q, et al.Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient[J]. Nephrology (Carlton),2014,19(4):186-194.
[25] Shao X, Tian L, Xu W, et al.Diagnostic value of urinary kidney injury molecule 1 for acute kidney injury: a meta-analysis[J]. PLoS One,2014,9(1):e84131.
[26] Maatman RG, van de Westerlo EM, van Kuppevelt TH, et al. Molecular identification of the liver-and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction[J]. Biochem J,1992,288(Pt 1):285-290.
[27] Kamijo-Ikemori A, Sugaya T, Matsui K, et al.Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice[J]. Nephrology (Carlton),2011,16(6):539-544.
[28] Basile DP, Leonard EC, Beal AG, et al.Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity[J]. Am J Physiol Renal Physiol,2012,302(11):F1494-F1502.
[29] Hamilton JA, Era S, Bhamidipati SP, et al.Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin[J]. Proc Natl Acad Sci U S A,1991,88(6):2051-2054.
[30] Kees-Folts D, Sadow JL, Schreiner GF.Tubular catabolism of albumin is associated with the release of an inflammatory lipid[J]. Kidney Int,1994,45(6):1697-1709.
[31] Kwiecien S, Jasnos K, Magierowski M, et al.Lipid peroxi-dation, reactive oxygen species and antioxidative factors in the pathogenesis of gastric mucosal lesions and mecha-nism of protection against oxidative stress-induced gastric injury[J]. J Physiol Pharmacol,2014,65(5):613-622.
[32] Yamamoto T, Noiri E, Ono Y, et al.Renal L-type fatty acid--binding protein in acute ischemic injury[J]. J Am Soc Nephrol,2007,18(11):2894-2902.
[33] Xie Y, Xu W, Wang Q, et al.Urinary excretion of liver-type FABP as a new clinical marker for the progression of obstructive nephropathy[J]. Biomark Med,2014,8(4):543-556.
[34] Waanders F, van Timmeren MM, Stegeman CA, et al. Kidney injury molecule-1 in renal disease[J]. J Pathol,2010,220(1):7-16.
[35] van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease[J]. J Pathol,2007,212(2):209-217.
[36] Waanders F, Vaidya VS, van Goor H, et al. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial[J]. Am J Kidney Dis,2009,53(1):16-25.
[37] van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant reci-pients[J]. Transplantation,2007,84(12):1625-1630.
[38] Humphreys BD, Xu F, Sabbisetti V, et al.Chronic epi-thelial kidney injury molecule-1 expression causes murine kidney fibrosis[J]. J Clin Invest,2013,123(9):4023-4035.
[39] Tian L, Shao X, Xie Y, et al.Kidney injury molecule-1 is elevated in nephropathy and mediates macrophage activation via the mapk signalling pathway[J]. Cell Physiol Biochem. 2017;41(2):769-783.
[40] Mou S, Wang Q, Li J, et al.Urinary excretion of liver-type fatty acid-binding protein as a marker of progressive kidney function deterioration in patients with chronic glomerulonephritis[J]. Clin Chim Acta,2012,413(1-2):187-191.
[41] Shah SN, Abramowitz M, Hostetter TH, et al.Serum bicarbonate levels and the progression of kidney disease: a cohort study[J]. Am J Kidney Dis,2009,54(2):270-277.
[42] Susantitaphong P, Sewaralthahab K, Balk EM, et al.Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review[J]. Am J Nephrol,2012,35(6):540-547.
[43] Gaggl M, Cejka D, Plischke M, et al.Effect of oral so-dium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)[J]. Trials,2013,14:196.
[44] Xie Y, Xue W, Shao X, et al.Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes[J]. PLoS One,2014,9(11):e112865.
[45] Sprenkle P, Russo P.Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate?[J]. Arch Esp Urol,2013,66(1):99-114. |
